Peginterferon α-2b in patients with chronic hepatitis C;Pegylowany interferon α-2b i rybawiryna w leczeniu przewlekłego wirusowego zapalenia wa̧troby typu C

Polski Merkuriusz Lekarski

Volumn 16, Issue 94, 2004, Pages 353-357

  Juszczyk, Jacek ^a   Białkowska, Jolanta ^b   Bolewska, Beata ^a   Boroń Kaczmarska, Anna ^c   Gładysz, Andrzej ^d   Halota, Waldemar ^e   Inglot, Małgorzata ^d   Janas Skulina, Urszula ^a   Jabłkowski, Maciej ^b   Jabłonska, Joanna ^f   Jurczyk, Krzysztof ^c   Kryczka, Wiesław ^g   Kuydowicz, Jan ^b   Lakomy, Elzbieta A ^h   Łyczak, Anna ⁱ   Mach, Tomasz ^a   Michalska, Zofia ^h   Moczko, Jerzy ^j   Modrzewska, Roma ⁱ   Nazzal, Khalil ^f   Pabjan, Paweł ^g   Pawłowska, Małgorzata ^e   Piszko, Paweł ^d   Sikorska, Katarzyna ^h   Świȩtek, Katarzyna ^a   Tomasiewicz, Krzysztof ⁱ   Topczewska Staubach, Ewa ^e   Wawrzynowicz Syczewska, Marta ^c   Zareøbska Michaluk, Dorota ^g   Zejc Bajsarowicz, Małgorzata ^a   more..

^a Katedra i Klinika Chorob Zakaznych   (Poland)

^b UM   (Poland)

^c Kat/Klin Chorob Zakaznych P   (Poland)

^d Katedra i Klinika Chorob Zakaznych   (Poland)

^e Klinika Chorob Zakaznych   (Poland)

^f Instytutu Chorob Zakaznych   (Poland)

^g Szpital Zespolonego   (Poland)

^h Klinika Chorob Zakaznych   (Poland)

ⁱ Katedra i Klinika Chorob Zakaznych   (Poland)

^j Kat i Zaklad Info i Statystyki   (Poland)

more..

Author keywords

Chronic viral hepatitis C; Combined treatment with pegylated interferon 2b and ribavirin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA; ALPHA2A INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALFA-2A; PEGINTERFERON ALPHA2A;

ABDOMINAL PAIN; ACUTE RESPIRATORY FAILURE; ADULT; ANEMIA; ANOREXIA; AORTA DISEASE; ARTICLE; BACTERIAL INFECTION; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DEPRESSION; DIARRHEA; DRUG EFFICACY; EPISTAXIS; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; GRANULOCYTOPENIA; HAIR LOSS; HEADACHE; HEPATITIS C; HEPATITIS C VIRUS; HOARSENESS; HUMAN; KNEE PAIN; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; MENSTRUATION DISORDER; MOOD DISORDER; MUSCLE WEAKNESS; MYALGIA; NAUSEA; NEUROPATHY; OPTIC NERVE DISEASE; PARANOID PSYCHOSIS; PHARYNGITIS; RECURRENCE RISK; RETROSTERNAL PAIN; SINUS BRADYCARDIA; SLEEP DISORDER; THROAT DISEASE; THYROID DISEASE; TINNITUS; UPPER RESPIRATORY TRACT INFECTION; VIRUS LOAD; WEIGHT REDUCTION; AGED; DRUG COMBINATION; MIDDLE AGED;

ADULT; AGED; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RIBAVIRIN;

EID: 2542501554     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Davis G.L. i wsp.: Monitoring of viral levels during therapy of hepatitis C. Hepatology, 2002, 36 (Suppl. 1), S145-151.
2. Fried M.W. i wsp.: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med., 2002, 347, 975-82.
3. Gabriel A., Ziółkowski A.: New terminology of chronic hepatitis, including a scoring scale. Med. Sci. Monitor, 1997, 3, 113-18.
4. Hadziyannis S.J. i wsp.: Peginterferon alfa-2a (40 kD) in combination with ribavirin, efficacy and safety results from a phase III randomized, double-blind multicenter study examing the effect of duration of treatment and RBV dose. J. Hepatol., 2002, (Suppl. 1), 3.
5. Jacobsen I. i wsp.: Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C. A trial in prior-non-responders to interferon monotherapy and in combination therapy nonresponders. Gastroenterology, 2002, 36 (Suppl. 1), A626 (streszcz.).
6. Juszczyk J. i wsp.: Efektywność leczenia przeciwwirusowego przewlekłego wirusowego zapalenia wa̧troby typu C (wieloośrodkowe badania polskie). Pol. Merk. Lek., 2001, 11, 340-3.
7. Juszczyk J.: Pegylowane interferony w leczeniu przewleklych wirusowych zapaleń wa̧troby typu C. Med. Sci. Rev., Hepatologia, 2002, wyd. 2 (red. J. Socha), 128-134.
8. Kjaergard L. i wsp.: Interferon alfa with or without ribavirin for chronic hepatitis C, systematic review of randomized trials. Brit. Med. J., 2001, 328, 1151-1155.
9. Manns M.P. i wsp.: Peginterferon alfa-2b plus ribavirin compared with interferon alfa 2b plus ribavirin for initial treatment of chronic hepatitis C, a randomized trial. Lancet, 2001, 358, 958-65.
10. McHutchinson J.G., Patel K.: Approach to treatment of chronic hepatitis C. W: M. Buti, R. Esteban (red.): Viral hepatitis. Acción Médica SA, Madrid 2003, s. 153-9.
11. Poynard T. i wsp.: Is an "a la carte" combination Interferon alfa-2b plus Rybavirin regimen possible for the first line treatment in patients with chronic hepatitis C. Hepatology, 2000, 31, 211-18.
12. Poynard T. i wsp.: Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology. 2002, 122, 1303-13.
13. Schiffman M.L. i wsp.: A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia. Gastroenterology, 1999, 117, 1164-72.
14. Schiffman M.L.: Management of interferon therapy nonresponders. Clin. Liver Dis., 2001, 5, 1025-43.
15. Trepo C. i wsp.: Pegylated interferon alfa-2b monotherapy is superior to interferon alfa-2b for the treatment of chronic hepatitis C. J. Hepatol., 2000, 32 (Suppl. 2), 29.
16. Zeuzem S. i wsp.: Interferon alfa 2a in patients with chronic hepatitis C. N. Engl. J. Med., 2000, 343, 1666-72.